HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story (Q33594187)

28 July 2017

1 reference

title

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story (English)

1 reference

28 July 2017

1 reference

Hicklin DJ

1

1 reference

28 July 2017

Marincola FM

series ordinal

2

1 reference

28 July 2017

Ferrone S

series ordinal

3

1 reference

28 July 2017

publication date

1 April 1999

1 reference

Trends in Molecular Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

5

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

178-186

1 reference

Structure, function, and diversity of class I major histocompatibility complex molecules

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Antigen presentation by major histocompatibility complex class I-B molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Antigen processing and presentation by the class I major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Mechanisms of MHC class I--restricted antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

The structure of the T cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Protection from natural killer cell-mediated lysis by HLA-G expression on target cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Multiple receptors for HLA-G on human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Inhibitory MHC class I receptors on NK cells and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901451-3

7 January 2021

10.1016/S1357-4310(99)01451-3

Identifiers

DOI

1 reference

28 July 2017

1 reference